China Biotech Services Holdings (HKSE:08037) Market Cap : HK$361.2 Mil (As of Jun. 07, 2024)

View and export this data going back to 2004. Start your Free Trial

What is China Biotech Services Holdings Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). China Biotech Services Holdings's share price for the quarter that ended in Dec. 2023 was HK$0.77. China Biotech Services Holdings's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 963.2 Mil. Therefore, China Biotech Services Holdings's market cap for the quarter that ended in Dec. 2023 was HK$741.7 Mil.

China Biotech Services Holdings's quarterly market cap declined from Jun. 2023 (HK$818.7 Mil) to Sep. 2023 (HK$626.1 Mil) but then increased from Sep. 2023 (HK$626.1 Mil) to Dec. 2023 (HK$741.7 Mil).

China Biotech Services Holdings's annual market cap declined from Dec. 2021 (HK$1,329.3 Mil) to Dec. 2022 (HK$1,107.7 Mil) and declined from Dec. 2022 (HK$1,107.7 Mil) to Dec. 2023 (HK$741.7 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. China Biotech Services Holdings's Enterprise Value for Today is HK$365.4 Mil.

China Biotech Services Holdings Market Cap Historical Data

The historical data trend for China Biotech Services Holdings's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Biotech Services Holdings Market Cap Chart

China Biotech Services Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Market Cap

Get a 7-Day Free Trial

1,241.35

1,256.91

1,329.26

1,107.72

741.69

China Biotech Services Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Market Cap	Get a 7-Day Free Trial															1,107.72	982.50	818.75	626.10	741.69

Competitive Comparison of China Biotech Services Holdings's Market Cap

For the Diagnostics & Research subindustry, China Biotech Services Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Biotech Services Holdings's Market Cap Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, China Biotech Services Holdings's Market Cap distribution charts can be found below:

* The bar in red indicates where China Biotech Services Holdings's Market Cap falls into.

China Biotech Services Holdings Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

China Biotech Services Holdings's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	HK$0.77	*	963.231
	=	HK$741.7

China Biotech Services Holdings's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )	=	Share Price (Q: Dec. 2023 )	*	Shares Outstanding (EOP) (Q: Dec. 2023 )
	=	HK$0.77	*	963.231
	=	HK$741.7

China Biotech Services Holdings (HKSE:08037) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

China Biotech Services Holdings Market Cap Related Terms

Thank you for viewing the detailed overview of China Biotech Services Holdings's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

China Biotech Services Holdings (HKSE:08037) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » China Biotech Services Holdings Ltd (HKSE:08037) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

255-257 Gloucester Roaad, Suites 1904-05A, 19th Floor, Sino Plaza, Causeway Bay, Hong Kong, HKG

Website

http://www.cbshhk.com

China Biotech Services Holdings Ltd is an investment holding company. It operates through six segments: Pharmaceutical Products, Medical and Health-Related Services, Immunotherapy, Securities, Insurance brokerage, BNCT and Others. It derives prime revenue from the Medical and health related services segment which involves the provision of medical laboratory testing and health check services. The group has a business presence in Hong Kong and the PRC, of which key revenue is generated from Hong Kong.

Executives

Liu Xiaolin	2101 Beneficial owner
Genius Earn Limited	2201 Interest of corporation controlled by you
Genius Lead Limited	2101 Beneficial owner
Guoyuan International Holdings Limited	2201 Interest of corporation controlled by you
Guoyuan Securities Co., Ltd.	2201 Interest of corporation controlled by you
Guoyuan Securities Investment (hong Kong) Limited	2101 Beneficial owner
Richlane Ventures Limited	2101 Beneficial owner
Ko Chun Shun, Johnson	2201 Interest of corporation controlled by you

China Biotech Services Holdings (HKSE:08037) Headlines

No Headlines